Sign in
Active, not recruitingNo phase

Early System Experience With the Abbott Balloon-expandable TAVI System: First-In-Human Study

Key facts

Who runs it
Abbott Medical Devices
Where
Georgia and Uzbekistan3 sites in 2 countriesChoose a country to see its sites
Trial code
Status
Active, not recruiting
People taking part
8 people enrolled
Started
21 Nov 2024
Expected to end
Sept 2027
Type of study
Interventional
Treatments tested
  • Balloon expandable TAVI
Record updated
8 April 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 9 criteriaShow less

Who can take part

  • Increased surgical risk
  • Appropriate anatomy
  • At least 18 years of age
  • Willing to return for follow-up assessments

Who cannot take part

  • Inoperable/ineligible for surgery
  • Anatomic or comorbid conditions
  • Evidence of acute myocardial infarction
  • Renal disease requiring chronic dialysis
  • Pregnant or nursing subjects

Where is this trial?

It has sites in 2 countries. Choose a country to see its sites.

About the trial

What the trial wants to find out

Early System Experience with the Abbott Balloon-expandable TAVI System

The group in the trial

  • Balloon expandable TAVITreatment being tested

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
EASE Study: Early System Experience With the Abbott Balloon-expandable TAVI System: First-In-Human Study
Record updated
8 April 2026